학술논문
AXL receptor tyrosine kinase inhibition improves the anti-tumor effects of CD8+ T cells by inducing CD103+ dendritic cell-mediated T cell priming
Document Type
Short Communication
Author
Source
In Biochemical and Biophysical Research Communications 5 November 2023 680:7-14
Subject
Language
ISSN
0006-291X